Tailor-Made Pentablock Copolymer Based Formulation for Sustained Ocular Delivery of Protein Therapeutics
Figure 18
Cell proliferation assay performed on RF/6A cells to evaluate the biological activity of bevacizumab (a) absorbance produced by live cells, (b) images of live cells including (1) negative control (untreated cells), (2) standard (cells exposed to 100 ng/mL of VEGF and 0.25 mg/mL of bevacizumab), (3) sample (cells exposed to 100 ng/mL of VEGF and 0.25 mg/mL of released bevacizumab), and (4) positive control (cell exposed to 100 ng/mL VEGF). Results are described in mean ± SD, .
